Johnson & Johnson orthopedics sales dip 0.5% in 2019: 5 things to know

Written by Laura Dyrda | January 22, 2020 | Print  |

Johnson & Johnson reported worldwide orthopedic sales of $8.8 billion in 2019, a 0.5 percent dip compared to 2018.

Five things to know:

1. During the fourth quarter, the company reported relatively flat orthopedics sales at $2.2 billion. U.S. sales grew 0.9 percent to $1.3 billion while international sales were flat at $904 million.

2. Worldwide hip sales were up 1.4 percent last year, hitting $1.4 billion. For the fourth quarter, hip sales jumped 3.4 percent to $377 million, with U.S. hip sales increasing nearly 5 percent.

3. Knee sales were down for the full year, dropping 1.4 percent to $1.4 billion. During the fourth quarter, knee sales were up 0.7 percent to $395 million, with U.S. sales remaining flat at $239 million.

4. Spine and other sales were down 2 percent worldwide in 2019, hitting $3.2 billion. The fourth quarter spine and other sales were down 1.8 percent, driven by international declines. U.S. spine and other sales also declined 1.6 percent to $488 million.

5. Worldwide trauma sales were up 0.8 percent last year, hitting $2.7 million. Fourth quarter U.S. trauma sales were up 2.3 percent to $413 million, and overall trauma sales were up 1.7 percent during the fourth quarter, hitting $686 million.

More articles on orthopedic devices:
Life Spine reports double-digit revenue growth, 7 new FDA gains in 2019
NuVasive, Alphatec report preliminary 2019 results & more: 11 device company notes
4 big devicemakers rival Intuitive Surgical in robotics — Medtronic, Stryker & more

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers